MARATTO

article · European Journal of Clinical Pharmacology

Most COVID-19 vaccine adverse events detected within 48 hours in Ethiopia: implications for cohort event monitoring efficiency in resource-limited settings

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s00228-026-04145-0

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.